Skip to main content

Albert Sabin

On April 12, 1955, Dr. Jonas Salk, a slightly built, forty-year-old research professor from the University of Pittsburgh, became a hero. On that morning, before one hundred and fifty news reporters and five hundred scientists and physicians crammed into an auditorium at the University of Michigan, “amid fanfare and drama far more typical of a Hollywood premiere than a medical meeting,” according to an account in The New York Times, it was announced that Dr. Salk had developed a vaccine that had been found effective in preventing poliomyelitis.

Subscribe to Albert Sabin

We hope you enjoyed this essay.

Please support this 70-year tradition of trusted historical writing and the volunteers that sustain it with a donation to American Heritage.

Donate

Stay informed - subscribe to our newsletter.
The subscriber's email address.